Bio M&A going strong. Biopharma M&A activity increased more than 100% in the first quarter of 2024 with 13 transactions in Q1 2024 compared to 6 transactions in Q1 2023
https://www.leerink.com/articles/analyzing-healthcare-ma-trends-q1-2024-insights/
Biopharmaceuticals remained the most active sub-sector of Healthcare and represented 34% of deal value and 45% of deal volume in Q1 2024 (vs. 63% of deal value and 21% of deal volume in Q1 2023).
Oncology was the most active therapeutic area, with 7 transactions totaling $9B in deal value.1Q 2024 BIOPHARMA | M&A ACTIVITY
Biopharma M&A activity increased more than 100% in the first quarter of 2024 with 13 transactions in Q1 2024 compared to 6 transactions in Q1 2023
Here's a couple more.
Vertex Pharmaceuticals is buying Alpine Immune Sciences for $4.9 billion
https://www.fiercebiotech.com/biotech/vertex-pays-49-billion-hike-alpines-immunology-trail
Takeda inks sweet $1.2B-plus deal with Kumquat for immuno-oncology program
https://www.fiercebiotech.com/biotech/takeda-inks-sweet-12b-deal-kumquat-immuno-oncology-program
This one is really interesting.
Genmab acquires privately owned biotech ProfoundBio for $1.8 billion in cash.
So ProfoundBio has 2 lead candidates PRO1184 and PRO1160. Both were set up as a phase 1/2 trial and neither had completed their estimated primary completion at the time of the buyout. PRO1160 estimated primary completion date was 30/4/2024 and PR01184 January 2025.
https://www.biospace.com/article/genmab-leans-into-hot-adc-space-with-1-8b-profoundbio-acquisition-/
https://www.profoundbio.com/Clinical-Trials
https://clinicaltrials.gov/study/NCT05579366
https://classic.clinicaltrials.gov/ct2/show/NCT05721222
So CHM 2101 trial has been set up the same, phase 1/2. Same amount of patients and same timeframe as PRO1184. It will not surprise me in the slightest if we get bought out in the next couple of years.
Right time and place.
- Forums
- ASX - By Stock
- CHM
- Chimeric: Media Thread
Chimeric: Media Thread, page-669
-
- There are more pages in this discussion • 164 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
|
|||||
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 539558 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 30000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 539558 | 0.017 |
17 | 2833886 | 0.016 |
19 | 2586784 | 0.015 |
3 | 708475 | 0.014 |
2 | 222223 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 30000 | 2 |
0.019 | 1360467 | 5 |
0.020 | 1473093 | 6 |
0.021 | 879092 | 4 |
0.022 | 600000 | 2 |
Last trade - 10.30am 02/09/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
Day chart unavailable
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online